Assignee: NPS Pharmaceuticals, Inc. (Salt Lake City, UT) Kirin Beer Kabushiki (Tokyo, JP) Primary Class: 514/654 Other Classes: 514/655, 564/341, 564/353, 564/354 International Classes: A61K31/165; A61K31/4035; A61P5/20; C07C211/30; C07C217/20; C07C217/58; C07C237/06; ...
Attorney, Agent or Firm: AUSTIN RAPP (SALT LAKE CITY, UT, US) Claims: What is claimed and desired to be secured by patent is: 1. An apparatus for detecting light transmitted from a composition disposed in one of a plurality of sample wells, said apparatus comprising: a single light ...
Soukup, Michael A. and Gary E. Machlis.American Covenant: National Parks, Their Promise, and Our Nation's Future. New Haven: Yale University Press, 2021. 216p.Swanson, Frederick H.Wonders of Sand and Stone: A History of Utah's National Parks and Monuments. Salt Lake City, UT: The Univ...
STOEL RIVES LLP - SLC (SALT LAKE CITY, UT, US) Claims: We claim: 1. A compound of formula I, or a salt, solvate or hydrate thereof ##STR10## wherein R is a group of formula III ##STR11## one of A, B, D and E is a N atom, the remainder being CH groups; ...
STOEL RIVES LLP - SLC (SALT LAKE CITY, UT, US) Parent Case Data: CROSS-REFERENCE TO RELATED APPLICATION This application is a divisional application of U.S. patent application Ser. No. 13/154,071, filed on Jun. 6, 2011, which issued as U.S. Pat. No. 8,257,983 on Sep. 4, 201...
Yusta, et al., “Enteroendocrine localization of GLP-2 receptor expression in humans and rodents”., Gastroenterology, 119, 2000, 744-755. Primary Examiner: HAMUD, FOZIA M Attorney, Agent or Firm: STOEL RIVES LLP - SLC (SALT LAKE CITY, UT, US) ...
STOEL RIVES LLP - SLC (SALT LAKE CITY, UT, US) Parent Case Data: This application is a continuation of application Ser. No. 08/091,437, filed Jul. 15, 1993, now abandoned, which is a divisional of application Ser. No. 07/896,437, filed Jun. 10, 1992, now abandoned. ...
ALLEN C TURNER (SALT LAKE CITY, UT, US) Claims: What is claimed is: 1. A process for preparing an R enantiomer of a compound having a formula (I): ##STR10## wherein Me is methyl, Ar is 3-methoxyphenyl, 3-chlorophenyl, or 1-naphthyl, and X is independently selected from the gro...
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide. Inventors: Sanguinetti, Elizabeth L. (Salt Lake City, UT, US) Marriott, Thomas B. (Sandy, UT, US) ...